ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Nasal Polyps
Rhinitis
Rhinosinusitis
Sinusitis
Conjunctivitis

Asthma trials near Los Angeles, CA, USA:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Enrolling
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

Palmdale, California, United States and 83 other locations

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

West Covina, California, United States and 331 other locations

The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma...

Enrolling
Mild Asthma
Combination Product: Albuterol
Combination Product: Albuterol/Budesonide

Phase 4

AstraZeneca
AstraZeneca

Lancaster, California, United States and 18 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Los Angeles, California, United States and 147 other locations

immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...

Enrolling
Asthma
Drug: Placebo
Drug: APG777

Phase 1

Apogee Therapeutics, Inc.

Torrance, California, United States and 9 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Enrolling
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Newport Beach, California, United States and 65 other locations

Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...

Active, not recruiting
Asthma
Drug: Asthma reliever therapies
Drug: Asthma controller therapies (incl. prednisone/prednisolone)

Phase 3

Sanofi
Sanofi

Rolling Hills Estates, California, United States and 79 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Los Angeles, California, United States and 247 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Los Angeles, California, United States and 314 other locations

in male and female participants aged 18 to 65 years (inclusive) with asthma.This study consists of a screening/run-in period, a treatment pe...

Enrolling
Asthma
Combination Product: Intervention: Ventolin Evohaler
Combination Product: Intervention: AS MDI

Phase 2

AstraZeneca
AstraZeneca

Los Angeles, California, United States and 24 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems